-
1.
公开(公告)号:US20200166527A1
公开(公告)日:2020-05-28
申请号:US16777444
申请日:2020-01-30
发明人: Surendra Sharma , Satyan Kalkunte , Udo Jeschke
摘要: Disclosed herein is a method of identifying and/or addressing incipient preeclampsia in a patient-subject by the steps of (a) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a said patient-subject at about 25 weeks of pregnancy or earlier; (b) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a pregnant non-preeclampsia one or more subjects at about 30 weeks of pregnancy or later, wherein said at least one sialyl Lewis antigen assay is for a sialyl Lewis antigen assayed in step (a) is and if more than one subject is assayed, averaging said results; and (c) managing said patient-subject for preeclampsia, if said level of at least one sialyl Lewis antigen of step (a) is at or greater than about 20% above the level of such silalyl Lewis antigen assayed in step (b).
-
2.
公开(公告)号:US09675664B2
公开(公告)日:2017-06-13
申请号:US14676132
申请日:2015-04-01
发明人: Surendra Sharma , Satyan Kalkunte , Udo Markert
IPC分类号: A61K38/16 , A61K38/00 , A61K38/17 , A61K31/196 , A61K31/60 , A61K31/603 , A61K31/616 , A61K38/38 , A61K45/06 , C07K14/47 , G01N33/78
CPC分类号: A61K38/1709 , A61K31/196 , A61K31/60 , A61K31/603 , A61K31/616 , A61K38/38 , A61K45/06 , C07K14/47 , G01N33/78 , A61K2300/00
摘要: This invention discloses a method of and composition for treating a PE-type disorder in a subject in need of such treatment comprising administering to the subject a pharmaceutical composition containing a therapeutically effective amount of a TTR polypeptide in admixture with a pharmaceutically acceptable vehicle.
-
公开(公告)号:US09572872B2
公开(公告)日:2017-02-21
申请号:US14426832
申请日:2013-09-09
发明人: Yow-Pin Lim , Barbara Stonestreet
CPC分类号: A61K38/57 , Y02A50/385 , Y02A50/393
摘要: The invention relates to methods of treatment of medical conditions (e.g., diseases and injuries) in a mammal (e.g., a human), such as hypoxia/ischemia, burns, and viral infections (e.g., influenza, West Nile virus, and Dengue fever), in adults and in children (e.g., neonates) by administering a composition that includes an IAIP.
摘要翻译: 本发明涉及治疗哺乳动物(例如人)中的医学病症(例如疾病和损伤)的方法,例如缺氧/缺血,烧伤和病毒感染(例如,流感,西尼罗病毒和登革热 ),在成人和儿童(如新生儿)中,通过施用包含IAIP的组合物。
-
公开(公告)号:US20170029459A1
公开(公告)日:2017-02-02
申请号:US15302898
申请日:2015-04-07
发明人: Rakesh K. Singh , Richard G. Moore
CPC分类号: C07J71/0042 , A61K31/401 , A61K31/415 , A61K31/565 , A61K31/575 , A61K31/58 , A61K45/06 , A61K2300/00
摘要: The present invention provides, in certain aspects, novel 7-dehydrocholesterol (7DHC) derivatives that are useful in treating or preventing cancer, as well as in treating or preventing uncontrolled angiogenesis, in a subject. In certain embodiments of the present invention, the subject is a human. In other aspects, the present invention provides a method of preparing compounds of the invention, or a salt or solvate thereof.
摘要翻译: 本发明在某些方面提供可用于治疗或预防癌症以及治疗或预防受试者中不受控制的血管发生的新型7-脱氢胆固醇(7DHC)衍生物。 在本发明的某些实施方案中,受试者是人。 在其它方面,本发明提供了制备本发明化合物或其盐或溶剂合物的方法。
-
公开(公告)号:US09168237B2
公开(公告)日:2015-10-27
申请号:US14254397
申请日:2014-04-16
发明人: Richard G. Moore , Rakesh K. Singh
IPC分类号: A01N37/00 , A61K31/21 , A61K31/198 , C07C333/20 , C07C331/20 , A61K31/26 , A61K31/27 , A61K45/06
CPC分类号: A61K31/198 , A61K31/26 , A61K31/27 , A61K45/06 , C07C331/20 , C07C333/20 , C07C2103/74 , C07C2603/74 , A61K2300/00 , A61K31/16
摘要: The present invention relates to adamantyl derivatives and their anti-cancer activity. Compounds of formulae I and II are provided as well as related methods of treatment and methods of synthesis.
摘要翻译: 本发明涉及金刚烷基衍生物及其抗癌活性。 提供式I和II的化合物以及相关的治疗方法和合成方法。
-
公开(公告)号:US20150238578A1
公开(公告)日:2015-08-27
申请号:US14426832
申请日:2013-09-09
发明人: Yow-Pin Lim , Barbara Stonestreet
IPC分类号: A61K38/57
CPC分类号: A61K38/57 , Y02A50/385 , Y02A50/393
摘要: The invention relates to methods of treatment of medical conditions (e.g., diseases and injuries) in a mammal (e.g., a human), such as hypoxia/ischemia, burns, and viral infections (e.g., influenza, West Nile virus, and Dengue fever), in adults and in children (e.g., neonates) by administering a composition that includes an IAIP.
摘要翻译: 本发明涉及治疗哺乳动物(例如人)中的医学病症(例如疾病和损伤)的方法,例如缺氧/缺血,烧伤和病毒感染(例如,流感,西尼罗河病毒和登革热 ),在成人和儿童(如新生儿)中,通过施用包含IAIP的组合物。
-
公开(公告)号:US20210052617A1
公开(公告)日:2021-02-25
申请号:US16961085
申请日:2019-01-16
发明人: Surendra Sharma
IPC分类号: A61K31/7016 , A61P15/00 , A61P9/12 , G01N33/68
摘要: Methods and compositions using trehalose or a derivative or prodrug thereof for treating pre-eclampsia in a subject are disclosed.
-
公开(公告)号:US20180321262A1
公开(公告)日:2018-11-08
申请号:US15889261
申请日:2018-02-06
发明人: Surendra Sharma , Satyan Kalkunte , Udo Jeschke
CPC分类号: G01N33/76 , A61K38/24 , G01N33/689 , G01N2400/10 , G01N2440/38 , G01N2800/368
摘要: Disclosed herein is a method of identifying and/or addressing incipient preeclampsia in a patient-subject by the steps of (a) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a said patient-subject at about 25 weeks of pregnancy or earlier; (b) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a pregnant non-preeclampsia one or more subjects at about 30 weeks of pregnancy or later, wherein said at least one sialyl Lewis antigen assay is for a sialyl Lewis antigen assayed in step (a) is and if more than one subject is assayed, averaging said results; and (c) managing said patient-subject for preeclampsia, if said level of at least one sialyl Lewis antigen of step (a) is at or greater than about 20% above the level of such silalyl Lewis antigen assayed in step (b).
-
公开(公告)号:US09982010B2
公开(公告)日:2018-05-29
申请号:US15302898
申请日:2015-04-07
发明人: Rakesh K. Singh , Richard G. Moore
IPC分类号: C07J71/00 , A61K31/401 , A61K31/415 , A61K31/565 , A61K31/575 , A61K31/58 , A61K45/06
CPC分类号: C07J71/0042 , A61K31/401 , A61K31/415 , A61K31/565 , A61K31/575 , A61K31/58 , A61K45/06 , A61K2300/00
摘要: The present invention provides, in certain aspects, novel 7-dehydrocholesterol (7DHC) derivatives that are useful in treating or preventing cancer, as well as in treating or preventing uncontrolled angiogenesis, in a subject. In certain embodiments of the present invention, the subject is a human. In other aspects, the present invention provides a method of preparing compounds of the invention, or a salt or solvate thereof.
-
公开(公告)号:US20240077500A1
公开(公告)日:2024-03-07
申请号:US18260661
申请日:2022-01-13
发明人: Surendra Sharma
CPC分类号: G01N33/6896 , G01N33/5091 , C12N2503/00 , G01N2333/4709 , G01N2800/28
摘要: The present disclosure relates in part to a blood-based method for the detection of a proteinopathy in a subject including, but not limited to, Alzheimer's disease (AD), mild cognitive impairment (MCI), and preeclampsia (PE), utilizing autophagy-deficient trophoblast (ADT) cells to sequester protein aggregates from the serum of said subject, and permit detection thereof. The present disclosure further relates to methods of treating, preventing, and/or ameliorating a proteinopathy in a subject by the administration of trehalose, a salt, solvate, stereoisomer, derivative, prodrug and or any mixture thereof.
-
-
-
-
-
-
-
-
-